BCR and chronic myelogenous leukemia, BCR-ABL1 positive: To date, monitoring the expression of BCR-ABL1 fusion gene by q-PCR and identifying ABL kinase mutations by sequencing have been employed as effective means to predict disease relapse and resistance in CML and ALL patients.